Terms: = Kidney tumors AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Clinical Outcome
53 results:
1. Undernutrition risk is independently associated with worsened indicators of hospital rehabilitation in COVID-19 patients.
Pinheiro VE; Ribeiro AS; Camillo CAM; Casonatto J
Hosp Pract (1995); 2023 Dec; 51(5):267-274. PubMed ID: 37897431
[TBL] [Abstract] [Full Text] [Related]
2. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic Accuracy Of Contrast Enhanced Ct For Detection Of Renal Cell Carcinoma Taking Histopathology As Gold Standard.
Akram F; Mazhar A; Javed H; Fayyaz M; Khan A; Ahmad K
J Ayub Med Coll Abbottabad; 2023; 35(1):84-87. PubMed ID: 36849383
[TBL] [Abstract] [Full Text] [Related]
4. Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Behrendt CE; Villalona-Calero MA; Newman EM; Frankel PH
Contemp Clin Trials; 2023 Feb; 125():107083. PubMed ID: 36638911
[TBL] [Abstract] [Full Text] [Related]
5. Metastatic Thyroid Carcinoma to the kidneys Presenting Initially as Bilateral Renal Masses: A Rare Case Report and Literature Review.
Youssef B; Hanna K; Bowman A; Ardor GD; Alhaj AM; Nassar A
Int J Surg Pathol; 2023 Aug; 31(5):795-800. PubMed ID: 36437643
[TBL] [Abstract] [Full Text] [Related]
6. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of kif11 is a poor prognostic factor in clear cell renal cell carcinoma.
Kowalewski A; Jaworski D; Antosik P; Smolińska M; Ligmanowska J; Grzanka D; Szylberg Ł
Pol J Pathol; 2022; 73(2):82-87. PubMed ID: 35979754
[TBL] [Abstract] [Full Text] [Related]
8. Association of sunitinib concentration and clinical outcome in patients with metastatic renal cell carcinoma treated with a 2-week-on and 1-week-off schedule.
Ito T; Yamamoto K; Furukawa J; Harada K; Fujisawa M; Omura T; Yano I
J Clin Pharm Ther; 2022 Jan; 47(1):81-88. PubMed ID: 34669974
[TBL] [Abstract] [Full Text] [Related]
9. clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
[TBL] [Abstract] [Full Text] [Related]
10. Localized Wilms' tumor in low-middle-income countries (LMIC): how can we get better?
Asfour HY; Khalil SA; Zakaria AS; Ashraf ES; Zekri W
J Egypt Natl Canc Inst; 2020 Aug; 32(1):32. PubMed ID: 32794016
[TBL] [Abstract] [Full Text] [Related]
11. Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma.
Lu H; Liang Y; Guan B; Shi Y; Gong Y; Li J; Kong W; Liu J; Fang D; Liu L; He Q; Shakeel M; Li X; Zhou L; Ci W
Theranostics; 2020; 10(10):4323-4333. PubMed ID: 32292497
[No Abstract] [Full Text] [Related]
12. Intra-tumor genetic heterogeneity in Wilms tumor samples.
de Sá Pereira BM; Azevedo RM; Aguirre Neto JC; Menezes CF; Rodrigues KE; Faria PA; Camargo B; Maschietto M
Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1496-1501. PubMed ID: 31994632
[TBL] [Abstract] [Full Text] [Related]
13. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract] [Full Text] [Related]
14. Long term outcomes after concurrent ipsilateral nephrectomy versus kidney-sparing surgery for high-risk, intraabdominal neuroblastoma.
Fahy AS; Roberts A; Nasr A; Irwin MS; Gerstle JT
J Pediatr Surg; 2019 Aug; 54(8):1632-1637. PubMed ID: 30029845
[TBL] [Abstract] [Full Text] [Related]
15. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With clinical Follow-up.
Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
[TBL] [Abstract] [Full Text] [Related]
16. Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy.
Kammerer-Jacquet SF; Medane S; Bensalah K; Bernhard JC; Yacoub M; Dupuis F; Ravaud A; Verhoest G; Mathieu R; Peyronnet B; Brunot A; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
Target Oncol; 2017 Aug; 12(4):487-494. PubMed ID: 28550387
[TBL] [Abstract] [Full Text] [Related]
17. Review of phase I and II trials for Wilms' tumour - Can we optimise the search for novel agents?
Brok J; Pritchard-Jones K; Geller JI; Spreafico F
Eur J Cancer; 2017 Jul; 79():205-213. PubMed ID: 28521171
[TBL] [Abstract] [Full Text] [Related]
18. MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes.
Doshi AM; Huang WC; Donin NM; Chandarana H
AJR Am J Roentgenol; 2015 Apr; 204(4):798-803. PubMed ID: 25794069
[TBL] [Abstract] [Full Text] [Related]
19. Use of 18F-FDG-PET-CT for Assessment of Response to Neoadjuvant Chemotherapy in Children With Wilms Tumor.
Qin Z; Tang Y; Wang H; Cai W; Fu H; Li J; Ma C
J Pediatr Hematol Oncol; 2015 Jul; 37(5):396-401. PubMed ID: 25749587
[TBL] [Abstract] [Full Text] [Related]
20. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma.
Girgis H; Masui O; White NM; Scorilas A; Rotondo F; Seivwright A; Gabril M; Filter ER; Girgis AH; Bjarnason GA; Jewett MA; Evans A; Al-Haddad S; Siu KM; Yousef GM
Mol Cancer; 2014 May; 13():101. PubMed ID: 24885701
[TBL] [Abstract] [Full Text] [Related]
[Next]
